Understanding BET inhibition as a novel pathway for cardiovascular risk modulation.
Topic:
Primary cardiovascular prevention: interventions and outcomes
Speaker:
Doctor J. Plutzky (Boston, US)
Organised by Academic Medical Center Amsterdam. Dept Vascular Medicine and Physicians' Academy for Cardiovascular Education / Course Director: Prof John Kastelein / Supported by an unrestricted educational grant from Resverlogix
Event:
ESC Congress 2016
Congress Presentation
About the speaker
Doctor Jorge Plutzky
Brigham and Women's Hospital, Boston (United States of America)
5
presentations
0
follower
4 more presentations in this session
Introduction - A novel approach for high CV risk patients with diabetes: the potential of epigenetics.
Speaker: Professor S. Del Prato (Pisa, IT)
The high risk diabetes patient with cardiovascular disease: what else can we target to reduce cardiovascular risk?
Speaker: Professor K. Ray (London, GB)
BET inhibition in cardiovascular disease: a new dawn?
Speaker: Professor J. Kastelein (Amsterdam, NL)
Discussion & summary - A novel approach for high CV risk patients with diabetes: the potential of epigenetics.
Speaker: Professor K. Ray (London, GB) Professor S. Del Prato (Pisa, IT)
Access the full session
A novel approach for high CV risk patients with diabetes: the potential of epigenetics
Speakers:
Doctor J. Plutzky, Professor S. Del Prato, Professor K. Ray, Professor J. Kastelein, Professor K. Ray...
About the event
ESC 365 is supported by
